Subacute Hemodynamic Effects of Nebivolol in Man at Rest and During Exercise

Author:

De Crée Jean1,Geukens Hedwig1,Cobo Carlos1,Verhaegen Herman1

Affiliation:

1. Clinical Research Unit St. Bartholomeus, Jan Palfijn Hospital, Merksem, Belgium

Abstract

In a subacute experiment 7 apparently healthy volunteers received a daily oral dose of 5 mg nebivolol for seven days, followed by a seven-day washout period with placebo. From the first day during treatment with nebivolol, peak exercise heart rate and systolic blood pressure, as measured during a standard ized submaximal treadmill exercise, significantly decreased by 15% and 19% respectively. A prolonged treatment for one week did not further increase the response of exercise heart rate and systolic blood pressure to nebivolol. How ever, the ratio of preejection period (PEPc) to left ventricular ejection time (LVETc), an indirect and valuable measure of left ventricular performance, pro gressively and significantly decreased during the seven-day treatment period with nebivolol from a mean value of 0.37±0.012 to 0.31±0.009. The improve ment of systolic time intervals resulted from a shortening of the PEPc and a lengthening of the LVETc. At rest, heart rate did not change significantly with nebivolol, whereas both systolic and diastolic blood pressure gradually and sig nificantly lowered. The postexercise LVET c significantly shortened during treat ment with nebivolol, and this shortening was more pronounced after seven days of treatment. After discontinuation of treatment with nebivolol, all these effects persisted for more than thirty hours after the last intake and gradually returned to pretreatment values thereafter. From these data it appears that nebivolol effectively reduces blood pressure at rest and during exercise in healthy volun teers, beneficially influencing preload and afterload, as measured by systolic time intervals. The negative influence on myocardial contractility during the exercise test, generally observed with beta-adrenergic antagonists, does not oc cur with nebivolol. Presumably this is due to an ancillary property of nebivolol, neutralizing the negative inotropic effect due to beta blockade.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3